Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Evaluation of RGD peptide hydrogel in the posterior segment of the rabbit eye.

Wang XH, Li S, Liang L, Xu XD, Zhang XZ, Jiang FG.

J Biomater Sci Polym Ed. 2013;24(10):1185-97. doi: 10.1080/09205063.2012.745714. Epub 2012 Nov 22.

PMID:
23713422
2.

Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye.

Einmahl S, Savoldelli M, D'Hermies F, Tabatabay C, Gurny R, Behar-Cohen F.

Invest Ophthalmol Vis Sci. 2002 May;43(5):1533-9.

PMID:
11980871
3.
4.

Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.

Chen M, Li X, Liu J, Han Y, Cheng L.

J Control Release. 2015 Apr 10;203:109-17. doi: 10.1016/j.jconrel.2015.02.021. Epub 2015 Feb 17.

PMID:
25700623
5.

Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye.

Patel SR, Berezovsky DE, McCarey BE, Zarnitsyn V, Edelhauser HF, Prausnitz MR.

Invest Ophthalmol Vis Sci. 2012 Jul 1;53(8):4433-41. doi: 10.1167/iovs.12-9872.

6.

RGD peptide-assisted vitrectomy to facilitate induction of a posterior vitreous detachment: a new principle in pharmacological vitreolysis.

Oliveira LB, Meyer CH, Kumar J, Tatebayashi M, Toth CA, Wong F, Epstein DL, McCuen BW 2nd.

Curr Eye Res. 2002 Dec;25(6):333-40.

PMID:
12789539
7.

Posterior vitreous detachment with microplasmin alters the retinal penetration of intravitreal bevacizumab (Avastin) in rabbit eyes.

Goldenberg DT, Giblin FJ, Cheng M, Chintala SK, Trese MT, Drenser KA, Ruby AJ.

Retina. 2011 Feb;31(2):393-400. doi: 10.1097/IAE.0b013e3181e586b2.

8.

Evaluation of the biocompatibility of novel peptide hydrogel in rabbit eye.

Liang L, Xu XD, Chen CS, Fang JH, Jiang FG, Zhang XZ, Zhuo RX.

J Biomed Mater Res B Appl Biomater. 2010 May;93(2):324-32. doi: 10.1002/jbm.b.31562.

PMID:
20225215
9.

A Self-Assembling Peptide Gel as a Vitreous Substitute: A Rabbit Study.

Uesugi K, Sakaguchi H, Hayashida Y, Hayashi R, Baba K, Suganuma Y, Yokoi H, Tsujikawa M, Nishida K.

Invest Ophthalmol Vis Sci. 2017 Aug 1;58(10):4068-4075. doi: 10.1167/iovs.17-21536.

PMID:
28820922
10.

Intraocular use of hydrogel tissue adhesive in rabbit eyes.

Sueda J, Fukuchi T, Usumoto N, Okuno T, Arai M, Hirose T.

Jpn J Ophthalmol. 2007 Mar-Apr;51(2):89-95. Epub 2007 Apr 6.

PMID:
17401616
11.

Drug delivery to the posterior segment of the eye through hydrogel contact lenses.

Schultz C, Breaux J, Schentag J, Morck D.

Clin Exp Optom. 2011 Mar;94(2):212-8. doi: 10.1111/j.1444-0938.2010.00553.x. Epub 2010 Dec 22.

12.

Ocular biocompatibility of a poly(ortho ester) characterized by autocatalyzed degradation.

Einmahl S, Ponsart S, Bejjani RA, D'Hermies F, Savoldelli M, Heller J, Tabatabay C, Gurny R, Behar-Cohen F.

J Biomed Mater Res A. 2003 Oct 1;67(1):44-53.

PMID:
14517860
13.

Comparison of suprachoroidal drug delivery with subconjunctival and intravitreal routes using noninvasive fluorophotometry.

Tyagi P, Kadam RS, Kompella UB.

PLoS One. 2012;7(10):e48188. doi: 10.1371/journal.pone.0048188. Epub 2012 Oct 31.

14.

Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.

Kim H, Robinson MR, Lizak MJ, Tansey G, Lutz RJ, Yuan P, Wang NS, Csaky KG.

Invest Ophthalmol Vis Sci. 2004 Aug;45(8):2722-31.

PMID:
15277497
15.

Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.

Kato A, Kimura H, Okabe K, Okabe J, Kunou N, Ogura Y.

Invest Ophthalmol Vis Sci. 2004 Jan;45(1):238-44.

PMID:
14691179
16.

Biodegradation of different synthetic hydrogels made of polyethylene glycol hydrogel/RGD-peptide modifications: an immunohistochemical study in rats.

Herten M, Jung RE, Ferrari D, Rothamel D, Golubovic V, Molenberg A, Hämmerle CH, Becker J, Schwarz F.

Clin Oral Implants Res. 2009 Feb;20(2):116-25. doi: 10.1111/j.1600-0501.2008.01622.x. Epub 2008 Dec 1.

PMID:
19077154
17.

Biocompatibility and retinal support of a foldable capsular vitreous body injected with saline or silicone oil implanted in rabbit eyes.

Wang P, Gao Q, Jiang Z, Lin J, Liu Y, Chen J, Zhou L, Li H, Yang Q, Wang T.

Clin Exp Ophthalmol. 2012 Jan-Feb;40(1):e67-75. doi: 10.1111/j.1442-9071.2011.02664.x. Epub 2011 Oct 20.

PMID:
21883770
18.

Injection site and pharmacokinetics after intravitreal injection of immunoglobulin G.

Miura Y, Uematsu M, Teshima M, Suzuma K, Kumagami T, Sasaki H, Kitaoka T.

J Ocul Pharmacol Ther. 2011 Feb;27(1):35-41. doi: 10.1089/jop.2010.0112. Epub 2010 Dec 23.

PMID:
21182428
19.

A novel vitreous substitute of using a foldable capsular vitreous body injected with polyvinylalcohol hydrogel.

Feng S, Chen H, Liu Y, Huang Z, Sun X, Zhou L, Lu X, Gao Q.

Sci Rep. 2013;3:1838. doi: 10.1038/srep01838.

20.

An injectable thermosensitive polymeric hydrogel for sustained release of Avastin® to treat posterior segment disease.

Xie B, Jin L, Luo Z, Yu J, Shi S, Zhang Z, Shen M, Chen H, Li X, Song Z.

Int J Pharm. 2015 Jul 25;490(1-2):375-83. doi: 10.1016/j.ijpharm.2015.05.071. Epub 2015 May 28.

PMID:
26027491

Supplemental Content

Support Center